Iskandar A, Nursiloningrum E, Arthamin MZ, Olivianto E, Chandrakusuma MS (2017) The diagnostic value of urine lipoarabinomannan (LAM) antigen in childhood tuberculosis. In: Open forum infectious diseases, vol 4. Songkhla MN, Tantipong H, Tongsai S, Angkasekwinai N (2019) Lateral flow urine lipoarabinomannan assay for diagnosis of active tuberculosis in adults with human immunodeficiency virus infection: a prospective cohort study. īulterys MA, Wagner B, Redard-Jacot M, Suresh A, Pollock NR, Moreau E, Denkinger CM, Drain PK, Broger T (2020) Point-of-care urine LAM tests for tuberculosis diagnosis: a status update.
Mtmr 5 antibody skin#
Mamishi S, Pourakbari B, Marjani M, Mahmoudi S (2014) Diagnosis of latent tuberculosis infection among immunodeficient individuals: review of concordance between interferon-gamma release assays and the tuberculin skin test. Targowski T, Chelstowska S, Plusa T (2014) IGRA as a predictive factor of silent pulmonary changes in individuals following exposure to tuberculosis. Hoff ST, Peter JG, Theron G, Pascoe M, Tingskov PN, Aggerbeck H, Kolbus D, Ruhwald M, Andersen P, Dheda K (2016) Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection.
Mtmr 5 antibody trial#
Lancet Respir Med 5(4):259–268Īggerbeck H, Giemza R, Joshi P, Tingskov PN, Hoff ST, Boyle J, Andersen P, Lewis DJ (2013) Randomised clinical trial investigating the specificity of a novel skin test (C-Tb) for diagnosis of M.
Ruhwald M, Aggerbeck H, Gallardo RV, Hoff ST, Villate JI, Borregaard B, Martinez JA, Kromann I, Penas A, Anibarro LL (2017) Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. Int J Infect Dis 99:473–481Īggerbeck H, Ruhwald M, Hoff ST, Borregaard B, Hellstrom E, Malahleha M, Siebert M, Gani M, Seopela V, Diacon A (2018) C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: a phase 3 trial. Sci Rep 10(1):1–11Įribo OA, Leqheka MS, Malherbe ST, McAnda S, Stanley K, van der Spuy GD, Walzl G, Chegou NN (2020) Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis. GenevaĬho Y, Park Y, Sim B, Kim J, Lee H, Cho S-N, Kang YA, Lee S-G (2020) Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach.
World Health Organization (2019) Global tuberculosis report 2018.
0 kommentar(er)
